Severe hypomagnesaemia with tetany following ESHAP protocol

BACKGROUND: One patient with B-cell Non-Hodgkin's Lymphoma developed severe hypomagnesaemia and tetany 15 days after the first course of treatment with ESHAP protocol. This prompted a careful look at the incidence and severity of hypomagnesaemia during treatment with this combination chemotherapy. M...

全面介紹

書目詳細資料

發表在:	BMC Blood Disord
主要作者:	Majumdar, Gautam
格式:	Artigo
語言:	Inglês
出版:	BMC 2002
主題:	Research Article
在線閱讀:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC64621/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11801194/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1471-2326-2-1
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!